Colorcon || One Partner
Pharma Focus America
ACROBiosystems - Survey NA

Projects

The pharmaceutical projects listed in this phase are those that receive periodic global announcements.

BIOVECTRA Starts Work on mRNA Vaccine and Biomanufacturing Facility in Charlottetown

The mRNA Vaccine and Biomanufacturing Centre at Biovectras Charlottetown campus has begun development The 36,000squarefoot facility will be able to produce 160 million doses of mRNA vaccines per year, with 70 million doses packed and ready for commercial distribution

Cytiva || Biosimilars Webinar LONZA || Building new approach methodologies (NAMs)